Related Experiment Videos

Lipid management and the elderly

Michael H Davidson1, Sara B Kurlandsky, Ruth M Kleinpell

  • 1Chicago Center for Clinical Research, 515 North State Street, Suite 2700, Chicago, IL 60610. mdavidson@protocare.com

Preventive Cardiology
|August 21, 2004
PubMed

Insights

Advancing age increases coronary heart disease risk. Lowering high cholesterol (hypercholesterolemia) in older adults is effective for cardiovascular risk reduction, despite ongoing debate.

Area of Science:

  • Cardiology
  • Geriatrics
  • Preventive Medicine

Background:

  • Advancing age is a significant independent risk factor for coronary heart disease (CHD).
  • The role of hypercholesterolemia as a cardiovascular risk factor in the elderly population remains a subject of debate.
  • While specific large-scale trials in the elderly are lacking, existing data suggest benefits of cholesterol lowering.

Purpose of the Study:

  • To review key management strategies for hypercholesterolemia.
  • To assess the impact of cholesterol lowering on coronary heart disease risk reduction in the elderly.

Main Methods:

  • Review of evidence from intervention trials, focusing on older adult subgroups.
  • Analysis of the implications of hypercholesterolemia prevalence and CHD frequency in the elderly.
  • Discussion of management issues pertinent to elderly populations.

Main Results:

  • Evidence from existing trials supports the efficacy of lowering low-density lipoprotein cholesterol (LDL-C) in older adults.
  • Although relative risk may decrease with age, the absolute impact of treating hypercholesterolemia is substantial due to high CHD incidence in the elderly.
  • High prevalence of CHD in the elderly underscores the importance of managing cholesterol levels.

Conclusions:

  • Lowering elevated LDL-C is beneficial for reducing cardiovascular risk in the elderly.
  • Effective management of hypercholesterolemia is crucial for mitigating CHD risk in aging populations.
  • Further research and clinical guidelines should address the specific needs of elderly individuals regarding cholesterol management.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...